An Ebola flare-up in the Ituri region of DR Congo has killed at least 139 deaths and left 536 suspected cases, prompting the WHO to declare a public‑health emergency of international concern. Residents of mining towns such as Mongbwalu live in panic as the disease spread unchecked for weeks, reaching Goma, Kinshasa and even Uganda. Health officials fear further spillover.

Early alerts from community health workers vanished after a breakdown in reporting chains, allowing the rare Bundibugyo strain to slip past local diagnostics. Bunia’s lab, equipped only for the Zaire variant, failed to confirm cases, and mishandled samples meant for Kinshasa’s molecular platforms. The lapse highlights how western funding cuts have left basic surveillance and testing under‑resourced. Without swift aid, mortality could rise sharply.

International donors have now mobilised emergency funds and vaccine‑development partners, but armed‑group activity in eastern Congo threatens logistics and market access for NGOs. The crisis exposes a gap in pandemic‑preparedness financing that could deter future private‑sector engagement in African health markets. Immediate investment in reliable diagnostics and community outreach is the only way to contain the outbreak. Stakeholders watch procurement contracts closely.